Is Boston Scientific Corporation (BSX) A Good Stock To Buy Now? [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on BSX. Boston Scientific Corporation's share was trading at $69.48 as of March 20th. BSX's trailing and forward P/E were 35.81 and 20.12 respectively according to Yahoo Finance. Is BSX a good stock to buy? sfam_photo/Shutterstock.com Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. As a global leader in medical devices, BSX operates through its MedSurg and Cardiovascular segments, generating $20.1 billion in 2025 revenue and demonstrating strong organic growth across its core businesses. Read More: 15 AI Stocks That Are Quietly Making Investors Rich Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential Despite a recent 17.5% one-day selloff following Q4 2025 earnings, the pullback reflects short-term concerns over the Electrophysiology division missing expectations and cautious 2026 guidance, rat
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSXGlobeNewswire
- BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Unsustainable U.S. Electrophysiology Segment Growth Rate: Levi & KorsinskyBusiness Wire
- BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Overstating Electrophysiology Growth Projections: Levi & KorsinskyGlobeNewswire
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery [TheStreet.com]TheStreet.com
- DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [TheStreet.com]TheStreet.com
BSX
Earnings
- 2/4/26 - Beat
BSX
Sec Filings
- 3/18/26 - Form DEFA14A
- 3/18/26 - Form DEF
- 3/18/26 - Form ARS
- BSX's page on the SEC website